Royalty Pharma Plc (RPRX)
58.31
-0.74
(-1.25%)
USD |
NASDAQ |
Sep 15, 15:20
Royalty Pharma Price : 58.31 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 58.66 | 59.55 | 57.75 | 59.05 | 2.967M |
| Sep 11, 2026 | 58.95 | 59.54 | 58.35 | 58.61 | 2.596M |
| Sep 10, 2026 | 60.44 | 60.71 | 58.64 | 58.75 | 3.325M |
| Sep 09, 2026 | 60.60 | 60.80 | 59.31 | 60.59 | 4.345M |
| Sep 08, 2026 | 59.21 | 60.86 | 58.63 | 60.59 | 8.632M |
| Sep 04, 2026 | 63.55 | 64.38 | 63.43 | 63.96 | 3.403M |
| Sep 03, 2026 | 63.56 | 63.94 | 62.50 | 63.88 | 2.761M |
| Sep 02, 2026 | 62.66 | 63.28 | 62.03 | 63.11 | 3.144M |
| Sep 01, 2026 | 61.82 | 62.58 | 61.61 | 62.32 | 2.629M |
| Aug 31, 2026 | 60.80 | 61.68 | 60.39 | 61.41 | 3.895M |
| Aug 28, 2026 | 61.92 | 62.01 | 60.66 | 60.85 | 1.702M |
| Aug 27, 2026 | 61.42 | 62.35 | 61.01 | 61.92 | 2.094M |
| Aug 26, 2026 | 62.04 | 62.28 | 61.49 | 61.80 | 1.478M |
| Aug 25, 2026 | 61.33 | 62.46 | 60.87 | 62.07 | 1.705M |
| Aug 24, 2026 | 61.19 | 61.54 | 60.80 | 61.33 | 2.358M |
| Aug 21, 2026 | 60.53 | 61.60 | 60.37 | 61.31 | 2.325M |
| Aug 20, 2026 | 61.33 | 62.13 | 60.37 | 60.58 | 3.143M |
| Aug 19, 2026 | 60.12 | 61.80 | 59.75 | 61.73 | 3.257M |
| Aug 18, 2026 | 59.74 | 60.42 | 59.66 | 59.69 | 2.075M |
| Aug 17, 2026 | 58.36 | 59.49 | 58.18 | 59.45 | 2.360M |
| Aug 14, 2026 | 57.89 | 58.78 | 57.72 | 58.60 | 1.596M |
| Aug 13, 2026 | 59.50 | 59.58 | 57.94 | 58.56 | 2.517M |
| Aug 12, 2026 | 57.75 | 59.33 | 57.65 | 59.22 | 3.924M |
| Aug 11, 2026 | 58.04 | 58.63 | 57.76 | 57.79 | 2.394M |
| Aug 10, 2026 | 57.43 | 58.03 | 56.53 | 57.97 | 4.264M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 162.77 |
| Johnson & Johnson | 265.88 |
| Merck & Co., Inc. | 143.79 |
| Viatris, Inc. | 16.62 |
| ANI Pharmaceuticals, Inc. | 71.33 |
Price Related Metrics
| PE Ratio | 31.04 |
| PS Ratio | 12.08 |
| Price to Book Value | 3.804 |
| Price to Free Cash Flow | 50.03 |
| Earnings Yield | 3.22% |
| Market Cap | 25.99B |
| Operating PE Ratio | 19.38 |
| Normalized PE Ratio | 33.01 |